Vera Therapeutics, Inc. (VERA) Financials

VERA Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 175.6 million 51.9 million
2023-06-30 195.2 million 54.7 million
2023-03-31 209.6 million 51.9 million
2022-12-31 131.4 million 54.5 million

VERA Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -23.0 million 2.9 million
2023-06-30 -17.8 million 2.7 million
2023-03-31 -26.3 million 2.7 million
2022-12-31 -21.2 million 2.7 million

VERA Net Income

No data available :(

VERA Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 159.9 million - 4.5 million
2023-06-30 181.0 million - 5.1 million
2023-03-31 197.2 million 24.9 million 5.8 million
2022-12-31 114.7 million 24.8 million 6.5 million

VERA Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 44.4 million
2023-06-30 44.3 million
2023-03-31 37.7 million
2022-12-31 26.6 million

VERA Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 - 16.1 million 5.7 million -
2023-06-30 - 16.2 million 5.7 million -
2023-03-31 - 25.1 million 6.2 million -
2022-12-31 6000 26.7 million 6.9 million -

VERA Cost of Revenue

No data available :(

VERA

Price: $43.44

52 week price:
6.07
50.78

Earnings Per Share: -2.25 USD

P/E Ratio: -15.11

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Volume: 367897

Market Capitalization: 2.6 billion

Links: